A forum for researchers, students and applicants in the field of cyclodextrin technology
Veklury™ by Gilead Sciences, Inc., containing antiviral drug, remdesivir (REM) has received emergency authorization in the USA and in Europe
Drug Development and Delivery has published on excipients with the title: SPECIAL FEATURE – Excipients: Far From Inactive summarizing the
This retrospective comparative effectiveness research study was conducted from March 4 to August 29, 2020, in a 5-hospital health system
Drug combination strategies of repurposed drugs offer a number of advantages to monotherapies including the potential to achieve greater efficacy,
Drug Development & delivery published on the virtual 2020 Global Drug Bioavailability Enhancement Summit, which this past December showcased novel
The effect of 11 buffers as well as the effect of ionic strength were investigated on the binding between the
A new study funded by the National Institutes of Health will evaluate the effects of remdesivir in pregnant women who
Remdesivir (GS-5734; Gilead Sciences Inc., US) is an investigational nucleoside analog that acts as a competitive inhibitor of viral RNAdependent
A retrospective study based on data collected from Memorial Sloan-Kettering Cancer Center, New York shows high efficacy and low toxicity
Remdesivir initially was intravenously administrated to treat the Ebola disease however right now it has been administered to treat COVID-19
